Differentiation between hepatocellular carcinoma (HCC) and hepatic metastasis (HM) by mDIXON quant and IVIM imaging
Xue Ren1, Jiazheng Wang2, Liangjie Lin2, Zhigang Wu2, Qingwei Song1, Renwang Pu1, Lihua Chen1, Ying Zhao1, Tao Lin1, Qihao Xu1, and Ailian Liu1
1Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Philips Healthcare, Beijing, China
Hepatocellular carcinoma (HCC) and hepatic metastasis (HM) are associated with distinct treatment and prognosis, while the differential diagnosis of HCC and HM still remains challenging. This study aims to explore the value of mDIXON quant and IVIM imaging in the differential diagnosis of HCC and HM. Results shown that the combination of R2*and IVIM measurements may offer a good biomarker for differential diagnosis of HCC and HM.
This abstract and the presentation materials are available to members only;
a login is required.